2018
DOI: 10.1016/j.xphs.2018.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Biomedical Applications of Lumazine Synthase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 130 publications
1
17
0
Order By: Relevance
“…For a 3D structure modeled with PYRE2 in case of RibE [23] using published structures of RibH from B.subtilis and homologous RibE from E.coli, see Additional file 1: Figure S2 [24][25][26]. It has been considered as a drug target and may also have applications in biotechnology, vaccine carrier molecule development, and other fields due to its useful encapsulation abilities [27][28][29].…”
Section: Introductionmentioning
confidence: 99%
“…For a 3D structure modeled with PYRE2 in case of RibE [23] using published structures of RibH from B.subtilis and homologous RibE from E.coli, see Additional file 1: Figure S2 [24][25][26]. It has been considered as a drug target and may also have applications in biotechnology, vaccine carrier molecule development, and other fields due to its useful encapsulation abilities [27][28][29].…”
Section: Introductionmentioning
confidence: 99%
“…Lumazine synthase (LS), an enzyme involved in riboflavin biosynthesis, is distributed extensively in organisms, including archaea, eubacteria, bacteria, fungi, and plants. [112][113][114] With as many as 12 pentamers or more than 300 subunits, a number of porous shell-like structures have been reported, all of which were able to generate strong humoral and cellular immunity. [115,116] Foreign peptides or proteins inserted at its N-terminus do not disrupt general peptide folding, representing another example of a particulate base for the repetitive display of vaccine candidates.…”
Section: Lumazine Synthasementioning
confidence: 99%
“…74 The enzymes lumazine synthase and riboflavin synthase have been studied extensively with the aim of developing antibiotic drugs from inhibitors of these enzymes. 74,75 8-Ribityl lumazines 58 and 59 were first isolated from the mycelium of the fungus Eremothecium ashbyii, along with riboflavin (55) in 1956. 76 The structure of lumazine 58 was assigned by comparing its spectroscopic data with that of the known 6,7,8-trimethyllumazine.…”
Section: Journal Of Natural Productsmentioning
confidence: 99%
“…A total synthesis of penilumamides B−D (72−74) was reported in 2017. 93 Aspergilumamide A (75), which contains a glutamine residue linked to the anthranilate group, was isolated from a mangrove-derived fungus Aspergillus sp., along with penilumamide A (71). 94 The biosynthetic pathway of these lumazine peptides (71−75) was proposed to start from lumazine-6-carboxylic acid (25), formed via folic acid catabolism, followed by stepwise addition of the amino acid (methionine or glutamine) and anthranilic acid.…”
Section: ■ Lumazine Peptidesmentioning
confidence: 99%